ACADIA Pharmaceuticals Inc.
ACAD | NASDAQ
$26.68
+$0.29 (+1.08%)
Sep 22, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 177.7M | 319.59M | 188.66M | 114.85M | 147.44M | 326.03M |
Short-Term Investments | 641.99M | 436.4M | 250.21M | 301.98M | 373.27M | 305.93M |
Long-Term Investments | 7.85M | 8.77M | 5.77M | 12.97M | 3.6M | 7.07M |
Other Long-Term Assets | 80.6M | 70.1M | 5.1M | 5.31M | 12.38M | 378K |
Receivables | 148.23M | 104.7M | 102.35M | 63.08M | 65.34M | 50.28M |
Inventory | 34.67M | 21.95M | 35.82M | 6.64M | 7.88M | 9.68M |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 1.06B | 938.32M | 616.13M | 507.94M | 617.82M | 717.62M |
Property-Plant & Equipment | 54.87M | 50.79M | 56.47M | 61.59M | 66.32M | 56.44M |
Goodwill & Intangibles | 108.89M | 119.78M | 65.49M | n/a | n/a | 1.11M |
Total Long-Term Assets | 502.08M | 249.44M | 132.83M | 79.88M | 82.3M | 65M |
Total Assets | 1.56B | 1.19B | 748.96M | 587.81M | 700.12M | 782.62M |
Account Payables | 10.9M | 16.19M | 17.54M | 12.75M | 6.88M | 8.49M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 11.63M | n/a | 9.41M | n/a | n/a | 5.09M |
Other Current Liabilities | 67.83M | 36.55M | 92.31M | 49.51M | 25.9M | 52.46M |
Total Current Liabilities | 277.11M | 394.87M | 254.25M | 125.63M | 96.07M | 105.97M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 19.14M | 18.06M | 15.15M | 9.07M | 7.03M | 5.18M |
Total Long-Term Liabilities | 59.69M | 60.09M | 62.95M | 61.77M | 63.16M | 49.64M |
Total Liabilities | 336.81M | 454.96M | 317.2M | 187.4M | 159.23M | 155.61M |
Total Debt | 52.19M | 52M | 57.21M | 62M | 64.43M | 49.55M |
Book Value | 1.23B | 732.79M | 431.76M | 400.41M | 540.89M | 627.01M |
Book Value Per Share | 7.16 | 4.40 | 2.64 | 2.48 | 3.37 | 3.99 |
Common Stock | 16K | 16K | 16K | 16K | 16K | 16K |
Retained Earnings | -1.81B | -2.2B | -2.43B | -2.37B | -2.15B | -1.99B |
Comprehensive Income | 1.45M | 292K | 24K | -975K | -192K | 36K |
Shareholders Equity | 1.23B | 732.79M | 431.76M | 400.41M | 540.89M | 627.01M |
Total Investments | 649.84M | 445.17M | 255.98M | 314.95M | 376.87M | 313M |
Add to Watchlist
Select watchlists to add or remove ACAD